Abstract
The synthesis and antiproliferative activity of eleven 3-(pyrid-2-yl)-pyrazolines in two cancer cell lines are reported. X-ray crystallography was obtained of the lead compound 8i which was screened in the NCI 60 human tumour cell line and displayed sub-micromolar activity. Cell cycle analysis, in vitro tubulin assay and confocal microscopy are also reported and suggest that the lead compound disrupts microtubule formation.
| Original language | English |
|---|---|
| Pages (from-to) | 956-961 |
| Number of pages | 6 |
| Journal | MedChemComm |
| Volume | 4 |
| Issue number | 6 |
| Early online date | 23 Apr 2013 |
| DOIs | |
| Publication status | Published - 1 Jun 2013 |